These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks. Seki Y; Mizukami T; Kohno T Biomolecules; 2015 Sep; 5(4):2464-76. PubMed ID: 26437441 [TBL] [Abstract][Full Text] [Related]
3. Breaking down RET breakpoints in lung adenocarcinoma. Watanabe H; Brooks AN; Meyerson M J Thorac Oncol; 2014 May; 9(5):590-2. PubMed ID: 24722148 [TBL] [Abstract][Full Text] [Related]
4. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Ju YS; Lee WC; Shin JY; Lee S; Bleazard T; Won JK; Kim YT; Kim JI; Kang JH; Seo JS Genome Res; 2012 Mar; 22(3):436-45. PubMed ID: 22194472 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma. Go H; Jung YJ; Kang HW; Park IK; Kang CH; Lee JW; Ju YS; Seo JS; Chung DH; Kim YT Lung Cancer; 2013 Oct; 82(1):44-50. PubMed ID: 23932363 [TBL] [Abstract][Full Text] [Related]
6. RET fusion as a novel driver of medullary thyroid carcinoma. Grubbs EG; Ng PK; Bui J; Busaidy NL; Chen K; Lee JE; Lu X; Lu H; Meric-Bernstam F; Mills GB; Palmer G; Perrier ND; Scott KL; Shaw KR; Waguespack SG; Williams MD; Yelensky R; Cote GJ J Clin Endocrinol Metab; 2015 Mar; 100(3):788-93. PubMed ID: 25546157 [TBL] [Abstract][Full Text] [Related]
8. Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad. Matsubara D; Kanai Y; Ishikawa S; Ohara S; Yoshimoto T; Sakatani T; Oguni S; Tamura T; Kataoka H; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T J Thorac Oncol; 2012 Dec; 7(12):1872-1876. PubMed ID: 23154560 [TBL] [Abstract][Full Text] [Related]
9. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Nikiforov YE; Koshoffer A; Nikiforova M; Stringer J; Fagin JA Oncogene; 1999 Nov; 18(46):6330-4. PubMed ID: 10597232 [TBL] [Abstract][Full Text] [Related]
10. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Liu H; Hamoudi RA; Ye H; Ruskone-Fourmestraux A; Dogan A; Isaacson PG; Du MQ Br J Haematol; 2004 May; 125(3):318-29. PubMed ID: 15086412 [TBL] [Abstract][Full Text] [Related]
11. RET fusion gene: translation to personalized lung cancer therapy. Kohno T; Tsuta K; Tsuchihara K; Nakaoku T; Yoh K; Goto K Cancer Sci; 2013 Nov; 104(11):1396-400. PubMed ID: 23991695 [TBL] [Abstract][Full Text] [Related]
12. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis. Lin C; Wang S; Xie W; Chang J; Gan Y Cancer Biol Ther; 2015; 16(7):1019-28. PubMed ID: 25975578 [TBL] [Abstract][Full Text] [Related]
13. RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients. Sarfaty M; Moore A; Neiman V; Dudnik E; Ilouze M; Gottfried M; Katznelson R; Nechushtan H; Sorotsky HG; Paz K; Katz A; Saute M; Wolner M; Moskovitz M; Miller V; Elvin J; Lipson D; Ali S; Gutman LS; Dvir A; Gordon N; Peled N Clin Lung Cancer; 2017 Jul; 18(4):e223-e232. PubMed ID: 28082048 [TBL] [Abstract][Full Text] [Related]
14. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. Wang R; Pan Y; Li C; Zhang H; Garfield D; Li Y; Ye T; Hu H; Luo X; Li H; Zhang Y; Zhang J; Zhou X; Shen L; Pao W; Sun Y; Chen H J Thorac Oncol; 2014 Jun; 9(6):760-8. PubMed ID: 24481316 [TBL] [Abstract][Full Text] [Related]
16. Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. Suzuki M; Makinoshima H; Matsumoto S; Suzuki A; Mimaki S; Matsushima K; Yoh K; Goto K; Suzuki Y; Ishii G; Ochiai A; Tsuta K; Shibata T; Kohno T; Esumi H; Tsuchihara K Cancer Sci; 2013 Jul; 104(7):896-903. PubMed ID: 23578175 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Noncanonical RET Fusions in Non-Small-Cell Lung Cancer through DNA and RNA Sequencing. Xiang C; Guo L; Zhao R; Teng H; Wang Y; Xiong L; Han Y J Mol Diagn; 2022 Apr; 24(4):374-385. PubMed ID: 35063667 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma. Lee MS; Kim RN; I H; Oh DY; Song JY; Noh KW; Kim YJ; Yang JW; Lira ME; Lee CH; Lee MK; Kim YD; Mao M; Han J; Kim J; Choi YL Oncotarget; 2016 Jun; 7(24):36101-36114. PubMed ID: 27150058 [TBL] [Abstract][Full Text] [Related]
19. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728 [TBL] [Abstract][Full Text] [Related]
20. A novel KIF5B-ALK variant in nonsmall cell lung cancer. Wong DW; Leung EL; Wong SK; Tin VP; Sihoe AD; Cheng LC; Au JS; Chung LP; Wong MP Cancer; 2011 Jun; 117(12):2709-18. PubMed ID: 21656749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]